Table 1.

Correlation between RNF141 expression level and clinicopathological characteristics in 64 CRC patients.

Variables	No. of patients N (%)	RNF141 expression ($\overline{\mathit{x}}$ ± s)	P value
All cases	64 (100%)
Gender			0.189
Male	34 (53.13%)	1.02 ± 2.07
Female	30 (46.87%)	0.67 ± 0.29
Age			0.143
≥60	38 (59.38%)	1.03 ± 1.39
<60	26 (40.62%)	0.61 ± 0.98
Tumor location			0.703
Colon	30 (46.87%)	0.91 ± 0.96
Rectum	34 (53.13%)	0.81 ± 1.54)
Differentiation			0.879
Well or moderately	52 (81.25%)	0.84 ± 1.12)
Poorly	12 (18.75%)	0.90 ± 2.06
T stage			0.019(*)
T1 or T2	14 (21.88%)	0.46 ± 0.21
T3 or T4	50 (78.12%)	0.97 ± 1.49
Lymph node metastasis			0.675
No	40 (62.50%)	0.81 ± 1.50
Yes	24 (37.50%)	0.93 ± 0.88
AJCC stage			0. 172
I or II	39 (60.94%)	0.70 ± 1.06
III or IV	25 (39.06%)	1.10 ± 1.51

AJCC American Joint Committee on Cancer, T tumor; *P < 0.05.